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Editorial Comment
Late Reversibility: A
Viability Issue*
ELIAS H. BOTVINICK, MD, FACC
San Francisco, California
In this issue of the Journal, Yang et al. (1) assess the
frequency of late, 24 h reversibility or redistribution in
dynamic exercise single photon emission computed tomo-
graphic (SPECT) thallium-201 myocardial perfusion scinti-
grams. The subject is important for its implications regarding
radionuclide kinetics and its potential impact on the study
protocol. Most important is the clinical significance of "late
reversibility" of thallium defects and the influence it exerts
on our perception of myocardial viability. The evaluation of
these issues, especially the latter, requires a careful review
of the numerical data presented and comparison with data
from earlier publications, many of which were written or
stimulated by this group.
What is the cause of late reversibility? As the authors (1)
note, the mechanism most likely relates to decreased access
of the radionuclide at 4 h to relatively underperfused myo-
cardial regions. Earlier evidence (2) supported a relation
between late reversibility and the severity of coronary
stenosis with insufficient regional access of underperfused
tissue to the circulating radionuclide (what Yang et al. (1)
call "hypoperfusion at rest"). While this is an appealing
hypothesis, it leads to other questions regarding the other-
wise benign and generally subliminal nature of what must be
"ischemia at rest. "
Alternatively, reduced radionuclide access may relate to
a generalized unavailability of thallium-201 with inordinately
reduced blood levels due to sequestration in other tissues
(3). Just as high gastrointestinal perfusion with food inges-
tion before study can lead to suboptimal testing with reduced
sensitivity, so too can eating in the redistribution interval
lead to an underestimation of potentially reversible seg-
ments. Similar confounding factors, but likely of less con-
cern, are uptake in the endothelium of the injected vessel
and, of course, infiltration at the injection site. It is probable
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that not enough attention is given to patient activities after
stress imaging. Aprolonged period offasting, when possible,
could serve to maximize 4h redistribution, although it would
not be likely to resolve the issue. Other mechanisms that
foster redistribution or radionuclide access should be
sought.
Finally, technical/actors must be considered. With time,
intramyocardial thallium decreases as background levels rise
and target to background ratios plummet. These factors
contribute to the suboptimal images often seen at 24 h, which
may contribute to problems of interpretation. This has led
investigators to a variety of alternative approaches. Some (4)
have suggested an additional (1 mCi) injection of thallium at
the time of late imaging or even before 4 h imaging. In
addition to the possible increase in expense and radiation
exposure required by these methods, they would be unsuc-
cessful if underperfusion at rest was truly the cause of the
problem (5). Yang et al. (1) note that their "late redistribu-
tion images have satisfactory count statistics and are almost
always satisfactory for visual interpretation." Neither "sat-
isfactory" nor "almost always" is further defined. They do
credit their use of an initial 3 to 4 mCi dose and a longer
imaging time for their technical imaging success. However,
their dosage is already in conventional use and increased
imaging time would not be expected to improve image
statistics related to a poor target to background ratio,
although it could test patient tolerance. Furthermore, varia-
bles related to acquisition, such as patient motion or proc-
essing, axis of reconstruction or section alignment, as well as
soft tissue attenuation, may playa role (6). Technical factors
may also be the best explanation for the segments in the
current study that had normalized on 4 h imaging only to be
found underperfused at 24 h.
What is the significance of late reversibility? Late revers-
ibility appears to reflect viable, ischemic and threatened
myocardium and its implications are similar to those of the 4
h variety (7,8). Support for this conclusion comes from the
general relation of such segments to normal or minimally
reduced wall motion or, when related to significantly re-
duced regional motion, their association with improved
function and perfusion after revascularization (9). In this
way, late reversing segments bear all the diagnostic and
prognostic significance of earlier reversing segments. They
may, in fact, be more vulnerable if truly related to tight
coronary lesions and hypoperfusion at rest. Most important,
if late reversible segments were undetected, viable, salvage-
able segments would be confused with irreversible infarc-
tion, and an appropriate aggressive approach, possibly lead-
ing to interventions aimed at reperfusion, could be replaced
by conservative management or heart transplantation!
Recently, metabolic evaluation, identifying active glycol-
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ysis with 18F-2-deoxyglucose and positron emission tomog-
raphy, has been advocated as the only reliable method of
identifying viability in segments without redistribution at 4 h
(10,11). When studied metabolically and preoperatively (12),
these segments have been shown to predict wall motion
reversibility after revascularization. Although one study (13)
has similarly demonstrated the importance of positron emis-
sion tomography to assess viability in "fixed" segments at
24 h, the greater the number of segments with 24 h revers-
ibility, the more important would be 24 h imaging and the
less necessary expensive positron emission tomography.
Thus, the frequency of late reversibility and its extent, in
terms of both segments and patients with viable myocardium
not otherwise identified, will have a significant bearing on
the diagnostic and prognostic impact of the study, on the
study protocol and, secondarilY, on the application of the
technology of positron emission tomography. This critical
frequency assessment was the objective of the current effort
(1).
How often does late reversibility occur? Twenty myocar-
dial segments were evaluated in each of the 118 patients with
"nonreversible" defects at 4 h. Some of these, such as the
apical segment, overlap, and all represent some composite of
regions at adjacent levels. Because anatomic catheterization
correlation is not presented (nor was it possible, given the
study protocol) and assuming a minor incidence of technical
artifacts, we must assume a certain, albeit small, amount of
misinterpretation. Thus, each segment probably represents
somewhat less than 5% of left ventricular mass.
By the authors' less stringent criterion of reversibility in
at least one segment (1), late reversibility was demonstrated
in 164 segments among 62 patients (average 2.6 segments per
patient), or <13% of left ventricular mass per patient af-
fected. Although affecting 53% of the 118 patients studied, it
included only 22% of those 762 segments with nonreversible
defects at 4 h, 16% of post-stress defects and roughly 7% of
myocardial segments. There were 285 segments reversible at
4 h, representing 27% of post-stress defects. We are told that
among the 62 patients with late reversibility, in 36 patients
(58%) late reversibility involved two or fewer segments, or
<10% of left ventricular mass, whereas in 26 patients (42%)
there were 113 defects (69%) (average 4.5 segments per
patient), or roughly 20% to 25% of left ventricular mass per
patient affected.
Is delayed reversibility clinically important? According to
the data presented, late reversibility is frequent and makes a
major impact on the absolute amount of myocardium as-
sessed as viable in almost one-half (42%) of patients demon-
strating this pattern, or 22% of segments studied with
nonreversible defects at 4 h. Late reversibility of lesser
extent may also be clinically important: aiding diagnoses and
regional decisions regarding reperfusion therapy and influ-
encing prognosis assessment and treatment in patients with
large areas of infarction, where relatively limited regions of
viable myocardium at ischemic risk may be critical for
symptom control and survival. Yet, clearly, patients with
late nonreversibility often have associated segments with 4 h
reversibility or late nonreversibility. Clinical impact may
hinge, in some cases, on the nature of related image findings.
Extensive reversibility at 4 h may render moot the findings at
24 h.
The scoring system employed here does not recognize
partial redistribution, a common occurrence. Both fixed
defects and those partially reversible at 4 h were included in
this evaluation of segments not reversible at 4 h. This
procedure results in a bias toward the recognition of late
reversibility at the expense of early, 4 h reversibility. How-
ever, this is unrealistic, as no one currently doing this work
should label a segment that demonstrated apparent partial
reversibility as fixed, denoting irreversible scar. Similarly,
partial reversibility at 24 h would be assessed as fixed by the
scoring system applied. And, if 24 h imaging is so frequently
needed to assess the extent of viable myocardium, how can
we explain the many studies (14,15) demonstrating that the
presence and extent of defects that are reversible at 4 hare
independent indicators of prognosis? Given the unselected
nature of populations in prior studies, this comparative
difference suggests the importance of the analytic method
discussed earlier or a persistent selection bias.
Should late imaging always be performed when persistent
defects are present at 4 h? Although we currently pursue this
course, the delay in interpretation and its clinical impact,
compounded with the burden placed on imaging personnel
and equipment, make this an alteration in the imaging
protocol to be avoided if possible. Certainly, we should
further pursue defects fixed at 4 h if their extent or revers-
ibility could affect treatment or prognosis, as previously
noted. Again, the presence of extensive but partially revers-
ible defects at 4 h may reduce the importance of the late
study in specific cases. Furthermore, the extent of reversible
defects in patients with associated fixed defects might influ-
ence our need for further data and delayed imaging.
Another issue is our ability to identify at 4 h, on the basis
of clinical, electrocardiographic and functional cues, those
segments that might reverse on delayed imaging. Recent
studies (2,7) as well as the current work (1) suggest diffi-
culties, although Yang et al. (1) did not assess regional wall
motion. These, however, stand in contradistinction to prior
studies (8,9,16-18) that relate fixed defects to infarction, Q
waves and severe regional asynergy. Both may be true,
however, as we now know that resting wall motion abnor-
malities may relate to reversible ischemia, stunned or hiber-
nating myocardium (19,20), as well as to completed infarc-
tion.
Again, our inability to relate clinical and functional mark-
ers to those of perfusion reversibility and viability could be
due to a selected patient study group referred for late
imaging. Study of an unselected, consecutive population,
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including appropriate numbers of patients with previous
infarction, could possibly identify clinical factors related to
the likelihood of significant late reversibility.
While exceptions exist, preservation or normalization of
wall motion is a widely accepted marker for viability (2,4,7-
9,11,12,16,17,21-27) that can potentially reduce or eliminate
the need for late imaging in the presence of fixed defects at
4 h. This remains valid in the context of defects fixed at 24 h.
Preserved regional left ventricular function associated with a
fixed defect at 4 or 24 h suggests viable myocardium at
ischemic risk with high probability. If recognized at 4 h, this
functional observation may obviate the need for 24 h imag-
ing. When noted after 24 h study, it may eliminate the need
for further tests of viability, such as metabolic evaluation by
positron emission tomography.
Should we forgo 4 h study and perform delayed imaging at
24 h only? Unrevealed here is the number of patients with
defects reversible at 4 h, or the marginal postexercise studies
that are read as normal with confidence after viewing the 4 h
images. From the relation between segments reversible at 4
and 24 h in the late reversibility group and from our own
experience, we must assume the number of patients is
sizeable. Certainly these patients should be identified imme-
diately. Given the potential clinical impact of image findings
at 4h and the technical difficulties of 24 h imaging, we would
not want to delay image evaluation that could adversely
affect patient care and cost effectiveness. Also, it would
uniformly make the study a 2day test, adding inconvenience
and anxiety. Furthermore, applying this protocol in labora-
tories with a high incidence of nonreversible studies would
be to sacrifice quality to quantity, affecting a significant
number of patients demonstrating other patterns. To omit
the 4 h study in a patient "likely to show no redistribution at
4 h" (1) would be claiming the predictability of 4 h revers-
ibility or the greater likelihood of 24 h reversibility, a claim
we cannot now make. In short, rather than omit 4 h studies,
we would prefer to reduce the need for 24 h imaging.
Additionally, we would have to forgo any advantage to
image interpretation of the evaluation of "washout" (28).
This measurement, based on the myocardial kinetics of
thallium-201 and other factors, has been shown to make
image interpretation more objective and to add to the extent
of visually detected ischemia (29). To eliminate the 4h study
would remove access to this evaluation. Although the
"washout" evaluation is possibly not as useful in single
photon emission computed tomography as with planar im-
aging, do the authors suggest we ignore it altogether?
An alternative method assessed by some (30) requires
imaging at 4h only after a supplementary thallium dose. This
method presents potential problems related to dose, the loss
of washout analysis and the blunting of data related to
delayed postexercise radionuclide distribution; the latter
could differ from results of a recent rest injection. However,
as a benefit, it could simplify the imaging protocol, making
24 h imaging unnecessary, and a recent study (30) indicates
a great advantage of this method for viability assessment.
What are the implications for metabolic evaluation of
viability by positron emission tomography? The authors (1)
note previous studies (8,9,18) that relate a high frequency of
fixed defects at 4 h to viable myocardium. The presence of
late reversibility at 24 h would be one method to establish
viability without resorting to assessment by positron emis-
sion tomography. They note that "Liu et al. (8) reported that
75% of 16 myocardial segments with 4 h nonreversible
thallium-201 defects demonstrated normal perfusion after
successful coronary angioplasty." However, 11 of the 12
defects that improved demonstrated motion of the associ-
ated segment in the absence of related Q waves before
intervention, whereas 3 of 4 segments without change after
angioplasty were related to akinesia with associated Q
waves. Was 24 h imaging or positron emission tomography
needed here? Other studies evaluated factors predicting
viability in segments without reversibility at 4 h and related
the absence of infarction and active segmental wall motion to
the likelihood of improved scintigraphic perfusion on de-
layed imaging or after coronary bypass surgery.
Also noted were studies indicating that 45% to 72% of
segments not reversible at 4 hand 37% of those not revers-
ible at 24 h improved or normalized after revascularization
(7,18), whereas in another study, 58% of nonreversible
segments at 4 h demonstrated active metabolism on positron
emission tomography (10). But these studies are noted to
likely include a high selection bias, giving rise to the high
numbers of viable, nonredistributing segments. On the other
hand, Massie et al. (17) reported an excellent relation
between reversibility of perfusion defects at 4 h and func-
tional reversibility after nitroglycerin or after extrasystoles.
In another study (16), the current group demonstrated that
thallium-201 "redistribution scintigraphy (at 4 h) appears to
reliably distinguish viable from nonviable asynergic myocar-
dial zones, and predicts the response of these segments to
[coronary artery bypass grafting]." Here, 4 h preoperative
redistribution was noted in 90% of segments with reversible
asynergy after bypass surgery. The incidence of late revers-
ibility as an indicator of viability is unlikely to exceed the
incidence of defects that are fixed at 4 h but reversible after
reperfusion. After taking into account the varying method-
ology employed, the 36% incidence of late segmental revers-
ibility among all reversible segments noted in the current
study still appears high compared with the 10% or lower
incidence of 4 h fixed defects among reversible asynergic
segments in their earlier study and those of others (16,17).
Conclusions. The sum of evidence from these studies
suggests an incidence of approximately 10% to 20% of viable
segments among those that are nonreversible at 4 h. This
number can possibly be further reduced by reconsideration
of the need for additional assessment of partially reversible
segments and by careful correlation with regional wall
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motion and other clinical factors. The new technetium-99m-
based perfusion agents may foster such combined perfusion
and functional assessment (31).
That late reversibility occurs is not at issue. The ques-
tions are, how often does it occur as the only clue to
myocardial viability and how significant a clinical impact
does it make? The final figure will vary, of course, among
patient populations. However, it will surely have an impact
on our imaging protocol and on the number of segments and
patients that will require metabolic evaluation by positron
emission tomography for assessment of viability.
I extend my deep appreciation to my University of California, San Francisco
physician and technologist colleagues who have contributed for years in the
effort, thought and experience that made these comments possible and to Drs.
Dae and Hattner for their specific input.
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